UroGen Pharma Ltd (URGN) valuation · rev $109.8M
UroGen Pharma Ltd (URGN) rev $109.8M.
| Metric | Value |
|---|---|
| Market cap | $1.61B |
| Revenue | $109.8M |
| P/S | 14.7 |
| P/B | 19.3 |
URGN valuation FAQ
What is URGN's market cap?
UroGen Pharma Ltd (URGN) market cap is $1.61B on the latest cached fundamentals snapshot.
What is URGN's latest revenue?
Latest cached UroGen Pharma Ltd (URGN) revenue was $109.8M. Statements: https://lician.com/financials/urgn
What is URGN's price-to-sales ratio?
UroGen Pharma Ltd (URGN) price-to-sales (P/S) is 14.7, cached market cap $1.61B divided by revenue $109.8M.
What is URGN's price-to-book ratio?
UroGen Pharma Ltd (URGN) price-to-book (P/B) is 19.3 on the latest cached fundamentals snapshot.
How many URGN valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for UroGen Pharma Ltd (URGN): Market cap, Revenue, P/S, and P/B.
Where is URGN valuation listed?
Cached valuation multiples for UroGen Pharma Ltd (URGN) are listed at https://lician.com/valuation/urgn.
Not investment advice. Cached rows, not a live tape.